Investor Overview

2018 was a strong year for our Tiara and Reducer product platforms. Both have achieved significant therapy development milestones, putting Neovasc on a stronger foundation from which to continue advancing these products commercially. We also have a clear value creation strategy for patients, employees, and investors. All of this is really good news for our outlook.

Read More >

Latest News

Neovasc Announces Second Quarter 2019 Financial Results

> read full release

Archive >

Programs and Events

Q1 2019 Earnings Call

webcast from May 9, 2019 live call
available until 08.09.19

replay >

2019 Q2 Financial Results

available 4.01pm (EST)
Wednesday, August 7, 2019

Financial Report Archive >

Financial Report Archives

2019 Financial Reports
  • Q1
  • Q2
  • Q3
  • Q4

News Release Archives

2019 News Releases

Share Information

Auditor
Grant Thornton LLP, Vancouver, BC

Legal Counsel
Blakes LLP, Vancouver, BC

Transfer Agent
Computershare, Vancouver, BC

Investor Relations
Chris Clark, Chief Financial Officer
investors@neovasc.com

To automatically receive news updates

register now